Evidence map›Paper›PMID 30275048›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2018

EF Hand Domain Family Member D2 Is Required for T Cell Cytotoxicity.

Michael Peled, Matthew A Dragovich, Kieran Adam, Marianne Strazza, Anna S Tocheva, Irving E Vega, Adam Mor

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Comparative Genomics Reveals 13 Different Isoforms of Mytimycins (A-M) inInternational journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Michael PeledPerlmutter Cancer Center, New York University School of Medicine, New York, NY 10016.
Matthew A DragovichPerlmutter Cancer Center, New York University School of Medicine, New York, NY 10016.
Kieran AdamPerlmutter Cancer Center, New York University School of Medicine, New York, NY 10016.
Marianne StrazzaPerlmutter Cancer Center, New York University School of Medicine, New York, NY 10016.ORCID 0000-0003-3106-1183
Anna S TochevaPerlmutter Cancer Center, New York University School of Medicine, New York, NY 10016.
Irving E VegaDepartment of Translational Science and Molecular Medicine, College of Human Medicine, Michigan State University, Grand Rapids, MI 49503; and.
Adam MorPerlmutter Cancer Center, New York University School of Medicine, New York, NY 10016; am5121@cumc.columbia.edu.
New York University · USColumbia University Irving Medical Center · USGrand Rapids Community College · USSheba Medical Center · IL

Funding

Novel mechanisms regulating PD-1 signaling and functionR01AI125640 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Adam Mor · 2016 to 2026
$4.3M
Brief Intervention for Marijuana Use among Latino YouthR01DA025640 · NIDA · FLORIDA INTERNATIONAL UNIVERSITY · PI WAGNER, ERIC F · 2009 to 2010
$1.3M
NIAID NIH HHS R01 AI125640NIDA NIH HHS R01 DA025640
6 · The paper itself

Abstract

Programmed cell death 1 (PD-1) is a major coinhibitory receptor and a member of the immunological synapse (IS). To uncover proteins that regulate PD-1 recruitment to the IS, we searched for cytoskeleton-related proteins that also interact with PD-1 using affinity purification mass spectrometry. Among these proteins, EF hand domain family member D2 (EFHD2), a calcium binding adaptor protein, was functionally and mechanistically analyzed for its contribution to PD-1 signaling. EFHD2 was required for PD-1 to inhibit cytokine secretion, proliferation, and adhesion of human T cells. Interestingly, EFHD2 was also required for human T cell-mediated cytotoxicity and for mounting an antitumor immune response in a syngeneic murine tumor model. Mechanistically, EFHD2 contributed to IS stability, lytic vesicles trafficking, and granzyme B secretion. Altogether, EFHD2 is an important regulator of T cell cytotoxicity and further studies should evaluate its role in T cell-mediated inflammation.

Indexed as

AnimalsCalcium-Binding ProteinsHumansImmunological SynapsesMiceT-Lymphocytes, CytotoxicCalcium-Binding ProteinsEFHD2 protein, humanEFHD2 protein, mouse

Identifiers

PMID30275048
PMCPMC6200634
OpenAlexW2894391519

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.